BestimБестим
What is it?
A gamma-linked D-Glu/L-Trp dipeptide studied in immune-cell binding experiments. It is distinct from Thymogen and Thymodepressin.
Research context
A gamma-linked D-Glu/L-Trp dipeptide studied in immune-cell binding experiments. It is distinct from Thymogen and Thymodepressin.
What the studies found
in vitro · 2008
Murine macrophages, thymocytes and isolated membranes
Radiolabeled gamma-D-Glu-L-Trp bound mouse immune cells; unlabeled Thymogen competed for binding. This supports a shared binding interaction under assay conditions, not equivalent immunological outcomes in people.
Limit: Cell-binding experiment, not a clinical trial.
Interaction of the synthetic immunomodulatory dipeptide bestim with murine macrophages and thymocytes ↗Selected findings, not a systematic review or a treatment recommendation. Combination and related-preparation results cannot be attributed to this compound alone. See each source for access status and remaining limitations.
- Working classification
- Peptide research family
- Research collection
- Peptide bioregulation · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —No human treatment trial assessed for this family
- Study methods
- —Member-specific studies; patents and archival leads identified separately
- Independent replication
- —Independent replication not established by the records collected here
- Source access
- —Primary abstracts, selected full texts, patents and explicit retrieval targets
- Safety evidence
- —Cell and animal effects do not establish human safety; analogues may differ
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Inside this research family
Grouping supports navigation. It does not imply equivalent composition, mechanisms, effectiveness or safety.
| Member | Identity | What the source supports |
|---|---|---|
| Bestim | γ-D-Glu-L-Trp | Primary binding paper specifies the linkage and stereochemistry. |
| Thymogen comparator | L-Glu-L-Trp | Competed in the binding assay; no equivalence of clinical effects follows. |
Interpretation and open questions
Changing linkage or stereochemistry changes the research object. Do not merge database synonyms without the original structure.
Linked sources
Explore the research map and unresolved leads ↗
Interaction of the synthetic immunomodulatory dipeptide bestim with murine macrophages and thymocytes
· Primary source linked above
Radiolabeled gamma-D-Glu-L-Trp bound mouse immune cells; unlabeled Thymogen competed for binding. This supports a shared binding interaction under assay conditions, not equivalent immunological outcomes in people.
- Population / setting
- Murine macrophages, thymocytes and isolated membranes
- What was checked
- Selected original-source text checked; full methodological review pending.
Limitations & review scope
- Cell-binding experiment, not a clinical trial.
- Preserve gamma linkage and D/L stereochemistry; generic database synonyms may be misleading.
Source checked 2026-10-05. This is a source-linked record, not a completed evidence review.